This company seems to have been delisted
Reason: Acquired by Ipsen
Last recorded trade on: May 5, 2023
Source: https://www.ipsen.com/press-releases/ipsen-completes-acquisition-of-albireo-expanding-the-scope-of-its-rare-disease-portfolio/
Reason: Acquired by Ipsen
Last recorded trade on: May 5, 2023
Source: https://www.ipsen.com/press-releases/ipsen-completes-acquisition-of-albireo-expanding-the-scope-of-its-rare-disease-portfolio/
Albireo Pharma
ALBO
$69.80
Share price
0.00%
Change (1 day)
127.12%
Change (1 year)
Categories
P/S ratio for Albireo Pharma (ALBO)
P/S ratio on May 5, 2023 (TTM) : 16.0
According to Albireo Pharma's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 9.15. At the end of 2022 the company had a P/S ratio of 6.62.
P/S ratio history for Albireo Pharma from 2010 to 2022
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2022 | 6.62 | -40.26% |
| 2021 | 11.1 | -87.16% |
| 2020 | 86.3 | 156.49% |
| 2019 | 33.6 | 45.93% |
| 2018 | 23.0 | -99.99% |
| 2017 | > 1000 | |
| 2016 | N/A | |
| 2015 | N/A | |
| 2014 | N/A | |
| 2013 | N/A | |
| 2012 | N/A | |
| 2011 | N/A | |
| 2010 | N/A |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 | N/A | N/A | 🇺🇸 USA |